Cargando…

Rituximab used for simultaneous treatment of PR3‐ANCA positive vasculitis associated with rheumatoid arthritis: A case report

We treated PR3‐ANCA positive vasculitis in a patient diagnosed with rheumatoid arthritis using rituximab. Monoclonal antibody therapy can be used to simultaneous treat more than one collagen disease in such patients. This suggests that shared pathogenic pathways exist between different collagen dise...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamada, Akihiro, Sogabe, Ayuko, Okuda, Yasuaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752559/ https://www.ncbi.nlm.nih.gov/pubmed/33363811 http://dx.doi.org/10.1002/ccr3.3258

Ejemplares similares

PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab
por: van Dam, Laura S, et al.
Publicado: (2020)

A Case Report Describing a Rare Presentation of Simultaneous Occurrence of MPO-ANCA-Associated Vasculitis and Rheumatoid Arthritis
por: Foray, Nathalie, et al.
Publicado: (2016)

PReS-FINAL-2311: Rituximab in paediatric ANCA-associated vasculitis
por: Mestrallet, G, et al.
Publicado: (2013)

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
por: Cortazar, Frank B., et al.
Publicado: (2017)

Co-trimoxazole and prevention of relapses of PR3-ANCA positive vasculitis with pulmonary involvement
por: Zycinska, K, et al.
Publicado: (2009)

Rhinologic and sinonasal changes in PR3 ANCA pulmonary vasculitis
por: Zycinska, K, et al.
Publicado: (2010)

A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocol
por: McClure, Mark E., et al.
Publicado: (2023)

Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis
por: Smith, Rona M, et al.
Publicado: (2020)

The Efficacy and Safety of Rituximab in ANCA-Associated Vasculitis: A Systematic Review
por: Habibi, Mohammad Amin, et al.
Publicado: (2022)

Rituximab-associated hypogammaglobulinemia in ANCA-associated vasculitis: Incidence and time course
por: Tariq, Anam, et al.
Publicado: (2022)

Clinical implications of serum thrombomodulin in PR3-ANCA-associated vasculitis
por: Zycinska, K, et al.
Publicado: (2009)

Acute PR3-ANCA vasculitis in an asymptomatic COVID-19 teenager
por: Wintler, Taylor, et al.
Publicado: (2021)

Association of ANCA associated vasculitis and rheumatoid arthritis: a lesser recognized overlap syndrome
por: Draibe, Juliana, et al.
Publicado: (2015)

Eye involvement in ANCA positive vasculitis
por: Macarie, Sorin Simion, et al.
Publicado: (2020)

Rituximab Treatment for PR3-ANCA-Positive Membranoproliferative Glomerulonephritis Associated with Adult-Onset Periodic Fever Syndrome
por: Hamano, Yoshitomo, et al.
Publicado: (2012)

A Case of Rituximab Use as an Induction and Maintenance of Remission in ANCA-Associated Vasculitis
por: Awad, Neveen, et al.
Publicado: (2016)

Rituximab Induction and Maintenance in ANCA-Associated Vasculitis: State of the Art and Future Perspectives
por: Treppo, Elena, et al.
Publicado: (2021)

Membranous Nephropathy with Proteinase 3-ANCA-associated Vasculitis Successfully Treated with Rituximab
por: Yoshida, Shun, et al.
Publicado: (2020)

COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab
por: Bruchfeld, Annette, et al.
Publicado: (2021)

Rituximab induction therapy for de novo ANCA associated vasculitis in pregnancy: a case report
por: Harris, Claire, et al.
Publicado: (2018)

Infection is associated with increased risk of MPO- but not PR3-ANCA-associated vasculitis
por: Rathmann, Jens, et al.
Publicado: (2022)

Simultaneous Automated Screening and Confirmatory Testing for Vasculitis-Specific ANCA
por: Sowa, Mandy, et al.
Publicado: (2014)

Ocular disease in patients with ANCA-positive vasculitis
por: Watkins, Angela S., et al.
Publicado: (2009)

Induction treatment of previously undiagnosed ANCA-associated vasculitis in a renal transplant patient with Rituximab
por: Graham-Brown, M. P. M., et al.
Publicado: (2016)

ANCA‐associated vasculitis with scleritis, corneal melt, and perforation rescued by rituximab: Case report and literature review
por: Matsuo, Toshihiko, et al.
Publicado: (2023)

Favorable efficacy of rituximab in ANCA-associated vasculitis patients with excessive B cell differentiation
por: Miyazaki, Yusuke, et al.
Publicado: (2020)

Long-term maintenance rituximab for ANCA-associated vasculitis: relapse and infection prediction models
por: McClure, Mark E, et al.
Publicado: (2020)

Membrane expression of neutrophil proteinase 3 (PR3) is associated with relapse in PR3-ANCA related vasculitis
por: Rarok, AA, et al.
Publicado: (2002)

PR3-ANCA-positive Pulmonary Cryptococcosis
por: Goto, Akihiko, et al.
Publicado: (2017)

Comparative investigation of respiratory tract involvement in granulomatosis with polyangiitis between PR3-ANCA positive and MPO-ANCA positive cases: a retrospective cohort study
por: Ikeda, Satoshi, et al.
Publicado: (2015)

Chemokine/Cytokine Levels Correlate with Organ Involvement in PR3-ANCA-Associated Vasculitis
por: Müller-Deile, Janina, et al.
Publicado: (2021)

A case of pulmonary fibrosis associated with rheumatoid arthritis, scleroderma sine scleroderma and ANCA associated vasculitis
por: Anand, Amritpal Singh, et al.
Publicado: (2014)

Review of tocilizumab in the treatment of rheumatoid arthritis
por: Okuda, Yasuaki
Publicado: (2008)

Specific IgG glycosylation differences precede relapse in PR3-ANCA associated vasculitis patients with and without ANCA rise
por: Wojcik, Iwona, et al.
Publicado: (2023)

ANCA associated vasculitis
por: Hunter, Robert W, et al.
Publicado: (2020)

Leukocytoclastic Vasculitis as a Rare Dermatologic Extraintestinal Manifestation of Ulcerative Colitis in an Elderly Patient with Positive PR3-ANCA
por: Ng, Jacky, et al.
Publicado: (2021)

Correction: Simultaneous Automated Screening and Confirmatory Testing for Vasculitis-Specific ANCA
por: Sowa, Mandy, et al.
Publicado: (2015)

Correction: Simultaneous Automated Screening and Confirmatory Testing for Vasculitis-Specific ANCA
Publicado: (2015)

Case report: de novo ANCA-associated vasculitis after kidney transplantation treated with rituximab and plasma exchange
por: Sagmeister, Michael S., et al.
Publicado: (2018)

Rituximab 500 mg 6-monthly infusions is an option in maintenance therapy of ANCA-associated vasculitis
por: Goel, Ruchika, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tusgp5lsroitl5i6h7m5qsneie